Douglas H. Thamm
Director Técnico/Científico/I+D en Csu Flint Animal Cancer Center .
Perfil
Douglas H.
Thamm is currently the Director of Clinical Research at CSU Flint Animal Cancer Center, Head of Clinical Development at VetDC, Inc., and a Member of the Cell & Molecular Biology Graduate Program at Colorado State University.
He received his undergraduate and doctorate degrees from the University of Pennsylvania.
Cargos activos de Douglas H. Thamm
| Empresas | Cargo | Inicio |
|---|---|---|
VetDC, Inc.
 VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Corporate Officer/Principal | - |
| Csu Flint Animal Cancer Center | Director Técnico/Científico/I+D | - |
| Colorado State University | Corporate Officer/Principal | - |
Formación de Douglas H. Thamm.
| University of Pennsylvania | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
VetDC, Inc.
VetDC, Inc. Agricultural Commodities/MillingProcess Industries VetDC, Inc. develops cancer drugs for pets. It is a cancer-focused veterinary biopharmaceutical company developing innovative, underutilized human technologies for use in companion animals. It offers VDC-1101, a novel anti-cancer pro-drug from Gilead Sciences for use in animal cancer. The company was founded by Terry J. Opgenorth in 2009 and is headquartered in Fort Collins, CO. | Process Industries |
| Csu Flint Animal Cancer Center |
- Bolsa de valores
- Insiders
- Douglas H. Thamm
